Prospective Multicenter Observational Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

Trial Profile

Prospective Multicenter Observational Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Embolism; Stroke; Thromboembolism; Thrombosis
  • Focus Therapeutic Use
  • Acronyms NEURO-XAR
  • Sponsors Bayer
  • Most Recent Events

    • 13 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov.
    • 17 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 13 Jun 2014 Planned end date changed from 1 Jun 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top